Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Lilly to buy Versanis for up to $1.93 billion to boost obesity drug portfolio By Reuters
© Reuters. FILE PHOTO: Eli Lilly logo is shown on one of the company’s offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File
Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion
Roivant, started by presidential candidate Vivek Ramaswamy, could seal a deal in coming days. Source link
Roivant in talks to sell bowel disease drug to Roche in over $7 billion deal
© Reuters. FILE PHOTO: A logo of Swiss pharmaceutical company Roche in Rotkreuz, Switzerland, April 12, 2012. REUTERS/Michael Buholzer/File Photo (Reuters) – Biotech company Roivant
Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion
Roivant, started by presidential candidate Vivek Ramaswamy, could seal a deal in coming days Source link
Sex, Drugs and Spreadsheets: Dr. Glazer Treats Wall Street's Addiction Surge
Demand has exploded for Dr. Glazer’s practice, which treats traders, fund managers and bankers who battle mental-health problems. Source link
In Battle With Microsoft, Google Bets on Medical AI Program to Crack Healthcare Industry
The search giant is fine-tuning chatbot technology via medical licensing exams. Source link
Factbox-Companies in Alzheimer’s race after US nod for Eisai/Biogen drug By Reuters
© Reuters. FILE PHOTO: The Alzheimer’s drug LEQEMBI is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai/Handout via REUTERS/File
Biogen stock whipsaws despite FDA granting full approval for Alzheimer’s drug; analysts explain why By Investing.com
© Reuters. FDA converts Biogen and Eisai’s Alzheimer’s treatment to traditional approval The U.S. Food and Drug Administration (FDA) converted the approval status of Leqembi
US FDA grants standard approval of Eisai/Biogen Alzheimer’s drug By Reuters
© Reuters. FILE PHOTO: The Alzheimer’s drug LEQEMBI is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai/Handout via REUTERS/File
FDA Forces the Only Drug for Preterm Births to Leave Market
Health Makena injections for pregnant women with previous early births are ineffective, agency says Source link